Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Neoplasms, Breast
Interventions: DRUG: Lapatinib|DRUG: capecitabine
Sponsor: GlaxoSmithKline